Skip to content
Use caution Drug recall · FDA · Published September 28, 2023

Eugia Triamcinolone Vial Recall: Glass Particles Risk

Eugia US LLC recalls 400 mg per 10 mL Triamcinolone Acetonide Injectable Suspension vials due to glass particles found in some units. This may cause injury during injection. Affected vials have NDC 55150-385-01 and were manufactured in India for Auromedics Pharma LLC.

🇺🇸 FDA recall #D-0041-2024DrugEugia ›
Take action

Contact the company

Recalling firmEugia US LLC279 Princeton Hightstown Rd · East Windsor, NJ 08520-1401
✎ GovInfoNow plain-language explainer

Eugia US LLC is recalling triamcinolone injectable vials after finding glass particles in some units. This could cause injury if injected, so affected users should stop using the product. Read more at govinfonow.com/recall/33093-eugia-triamcinolone-vial-recall-glass-particles-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/33093-eugia-triamcinolone-vial-recall-glass-particles-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0041-2024

Cite this page

“Eugia Triamcinolone Vial Recall: Glass Particles Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33093-eugia-triamcinolone-vial-recall-glass-particles-risk. Based on FDA recall #D-0041-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0041-2024%22&limit=1).

Eugia US LLC recalled Triamcinolone Acetonide Injectable Suspension, USP due to the presence of particulate matter, according to the FDA. The Food and Drug Administration announced the recall on September 28, 2023.

How to tell if you have it

  • Brand: Eugia
  • Product: Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial
  • NDC: 55150-385-01
  • Lot #: 3TC22010
  • Expiration Date: 11/30/2024

The hazard

A product complaint identified a piece of glass, roughly 1 cm x 0.5 cm, inside a vial. The record states the hazard is the presence of particulate matter.

Context

GovInfoNow's records show Eugia US LLC has 14 other recalls on record since December 28, 2022. Other recent recalls include an August 10, 2026 Fresenius Kabi Tyenne Injection recall for glass particles, a May 12, 2026 Sun Pharmaceutical DOXOrubin Liposome Injection recall for glass particulate risk, and an August 6, 2026 Mallinckrodt Acthar Gel 5mL Vial recall for particulate matter hazard.

How to tell if you have this one

Check for vials labeled 'Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial'. The NDC number is 55150-385-01 and was manufactured in India for Auromedics Pharma LLC.

  • Brand
    Eugia
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Vial Label

    Look for the NDC number 55150-385-01 on the vial label.

  2. Stop Using Vial

    If you have the recalled vial, do not use it for injections.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 13 days after the firm started it.

1. Firm started the recall: Sep 28, 202312. FDA classified it Class II: Oct 5, 202323. Published in FDA’s Enforcement Report: Oct 11, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What should I do if I have the recalled vial?

Do not use the vial for injections. Contact your doctor for alternative options.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0041-2024 (September 28, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0041-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA